Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Synergistic antiproliferative effect of imatinib and adriamycin in platelet-derived growth factor receptor-expressing osteosarcoma cells
Authors
Keywords
-
Journal
CANCER SCIENCE
Volume 106, Issue 7, Pages 875-882
Publisher
Wiley
Online
2015-05-02
DOI
10.1111/cas.12686
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- IGF2 Preserves Osteosarcoma Cell Survival by Creating an Autophagic State of Dormancy That Protects Cells against Chemotherapeutic Stress
- (2014) T. Shimizu et al. CANCER RESEARCH
- Recent advances in osteosarcoma
- (2014) Sander M Botter et al. CURRENT OPINION IN PHARMACOLOGY
- Imatinib Mesylate Exerts Anti-Proliferative Effects on Osteosarcoma Cells and Inhibits the Tumour Growth in Immunocompetent Murine Models
- (2014) Bérengère Gobin et al. PLoS One
- Twist2 functions as a tumor suppressor in murine osteosarcoma cells
- (2013) Tomoki Ishikawa et al. CANCER SCIENCE
- TNFα promotes osteosarcoma progression by maintaining tumor cells in an undifferentiated state
- (2013) T Mori et al. ONCOGENE
- Multifarious functions of PDGFs and PDGFRs in tumor growth and metastasis
- (2013) Yihai Cao TRENDS IN MOLECULAR MEDICINE
- Fibroblast Growth Factor-2 Is an Important Factor that Maintains Cellular Immaturity and Contributes to Aggressiveness of Osteosarcoma
- (2012) T. Shimizu et al. MOLECULAR CANCER RESEARCH
- Up-Regulation of Imp3 Confers In Vivo Tumorigenicity on Murine Osteosarcoma Cells
- (2012) Arisa Ueki et al. PLoS One
- Changes in mitochondrial redox state, membrane potential and calcium precede mitochondrial dysfunction in doxorubicin-induced cell death
- (2011) Andrey V. Kuznetsov et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Cell surface receptor expression patterns in osteosarcoma
- (2011) Sheref E. Hassan et al. CANCER
- Molecular alterations as target for therapy in metastatic osteosarcoma: a review of literature
- (2011) J. PosthumaDeBoer et al. CLINICAL & EXPERIMENTAL METASTASIS
- Tumor-Host Interactions: A Far-Reaching Relationship
- (2010) Sandra S. McAllister et al. JOURNAL OF CLINICAL ONCOLOGY
- Multicenter Phase II trial assessing effectiveness of imatinib mesylate on relapsed or refractory KIT-positive or PDGFR-positive sarcoma
- (2010) Hideshi Sugiura et al. JOURNAL OF ORTHOPAEDIC SCIENCE
- c-MYC overexpression with loss of Ink4a/Arf transforms bone marrow stromal cells into osteosarcoma accompanied by loss of adipogenesis
- (2010) T Shimizu et al. ONCOGENE
- Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
- (2009) Partha Mukhopadhyay et al. AMERICAN JOURNAL OF PHYSIOLOGY-HEART AND CIRCULATORY PHYSIOLOGY
- Serum deprivation-induced reactive oxygen species production is mediated by Romo1
- (2009) Seung Baek Lee et al. APOPTOSIS
- Correlation between clinical outcome and growth factor pathway expression in osteogenic sarcoma
- (2009) Ayesha Abdeen et al. CANCER
- Imatinib in the treatment of solid tumours
- (2009) Florence Duffaud et al. Targeted Oncology
- Platelet-derived growth factor receptor as a prognostic marker and a therapeutic target for imatinib mesylate therapy in osteosarcoma
- (2008) Tadahiko Kubo et al. CANCER
- Imatinib as effective therapy for dermatofibrosarcoma protuberans: proof of concept of the autocrine hypothesis for cancer
- (2008) Despina Handolias et al. Future Oncology
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started